Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 PolarityTEKiromic BioPharmaWindtree TherapeuticsBrickell BiotechAllena Pharmaceuticals
SymbolNASDAQ:PTENASDAQ:KRBPNASDAQ:WINTNASDAQ:BBINASDAQ:ALNA
Price Information
Current Price$0.95$9.37$2.34$0.97$1.23
52 Week RangeBuyN/ABuyBuyBuy
MarketRank™
Overall Score1.41.02.31.41.3
Analysis Score3.30.03.53.53.4
Community Score2.75.05.01.32.6
Dividend Score0.00.00.00.00.0
Ownership Score0.00.01.71.70.0
Earnings & Valuation Score1.30.01.30.60.6
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$4.00N/A$12.25$5.50$10.40
% Upside from Price Target320.61% upsideN/A423.50% upside467.01% upside745.53% upside
Trade Information
Market Cap$57.19 million$68.71 million$61.44 million$64.92 million$69.96 million
Beta1.29N/A0.250.342.39
Average Volume8,535,36522,202314,0953,642,2282,134,093
Sales & Book Value
Annual Revenue$5.65 millionN/A$200,000.00$7.92 millionN/A
Price / Sales10.12N/A307.218.20N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.42 per shareN/A$5.48 per share$0.97 per share$0.73 per share
Price / Book0.67N/A0.431.00N/A
Profitability
Net Income$-92,490,000.00N/A$-27,480,000.00$-23,880,000.00$-47,340,000.00
EPS($3.70)N/A($2.52)($5.11)($2.10)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-674.12%N/AN/A-990.67%N/A
Return on Equity (ROE)-169.92%N/A-43.46%-187.45%-207.07%
Return on Assets (ROA)-105.62%N/A-26.55%-114.85%-112.21%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%N/A0.18%N/A0.54%
Current Ratio3.22%N/A2.75%3.50%7.99%
Quick Ratio3.11%N/A2.75%3.50%7.99%
Ownership Information
Institutional Ownership Percentage16.51%N/A1.59%5.93%28.03%
Insider Ownership Percentage5.50%N/A14.91%10.30%22.80%
Miscellaneous
Employees15311311541
Shares Outstanding60.13 million7.33 million26.26 million66.93 million56.88 million
Next Earnings Date5/10/2021 (Estimated)6/30/2021 (Estimated)5/13/2021 (Estimated)5/12/2021 (Estimated)5/12/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Eiger BioPharmaceuticals (NASDAQ:EIGR) and Allena Pharmaceuticals (NASDAQ:ALNA) Head-To-Head SurveyEiger BioPharmaceuticals (NASDAQ:EIGR) and Allena Pharmaceuticals (NASDAQ:ALNA) Head-To-Head Survey
americanbankingnews.com - April 12 at 8:14 PM
Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Given Average Rating of "Buy" by BrokeragesAllena Pharmaceuticals, Inc. (NASDAQ:ALNA) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - April 9 at 9:03 AM
Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Expected to Announce Earnings of -$0.20 Per ShareAllena Pharmaceuticals, Inc. (NASDAQ:ALNA) Expected to Announce Earnings of -$0.20 Per Share
americanbankingnews.com - April 9 at 8:22 AM
Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - April 8 at 9:45 AM
How Many Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Shares Have Insiders Sold, In The Last Year?How Many Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Shares Have Insiders Sold, In The Last Year?
nasdaq.com - April 7 at 6:10 PM
Allena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of DirectorsAllena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of Directors
finance.yahoo.com - April 7 at 8:09 AM
Allena Pharmaceuticals (NASDAQ:ALNA) Trading Down 8.1%Allena Pharmaceuticals (NASDAQ:ALNA) Trading Down 8.1%
americanbankingnews.com - March 18 at 8:34 PM
Zacks Investment Research Downgrades Allena Pharmaceuticals (NASDAQ:ALNA) to SellZacks Investment Research Downgrades Allena Pharmaceuticals (NASDAQ:ALNA) to Sell
marketbeat.com - March 12 at 4:27 PM
Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides ...Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides ...
apnews.com - March 10 at 9:24 AM
Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateAllena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
finance.yahoo.com - March 9 at 8:24 AM
Top Penny Stocks On Robinhood If Biotech Is Your Focus Right NowTop Penny Stocks On Robinhood If Biotech Is Your Focus Right Now
marketwatch.com - February 24 at 10:48 PM
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in MarchAllena Pharmaceuticals to Present at Upcoming Investor Conferences in March
finance.yahoo.com - February 24 at 12:46 PM
Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) On Wednesday – Up 72.37 Percent From Lows, What To Expect Going Ahead?Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) On Wednesday – Up 72.37 Percent From Lows, What To Expect Going Ahead?
marketingsentinel.com - February 6 at 12:29 PM
Are Institutions Heavily Invested In Allena Pharmaceuticals, Inc.s (NASDAQ:ALNA) Shares?Are Institutions Heavily Invested In Allena Pharmaceuticals, Inc.'s (NASDAQ:ALNA) Shares?
finance.yahoo.com - February 5 at 7:51 AM
Allena Pharmaceuticals Appoints Richard D. Katz, M.D. as Chief Financial OfficerAllena Pharmaceuticals Appoints Richard D. Katz, M.D. as Chief Financial Officer
finance.yahoo.com - February 2 at 11:59 AM
Allena Pharmaceuticals Inc. ALNAAllena Pharmaceuticals Inc. ALNA
stockhouse.com - January 22 at 6:09 PM
Has Allena Pharmaceuticals (ALNA) Outpaced Other Medical Stocks This Year?Has Allena Pharmaceuticals (ALNA) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - January 12 at 5:27 PM
Allena Pharmaceuticals, Inc. (ALNA) Moves to Buy: Rationale Behind the UpgradeAllena Pharmaceuticals, Inc. (ALNA) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - January 12 at 5:27 PM
Allena Pharmaceuticals Price to Book Value:Allena Pharmaceuticals Price to Book Value:
ycharts.com - January 10 at 12:58 AM
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in JanuaryAllena Pharmaceuticals to Present at Upcoming Investor Conferences in January
finance.yahoo.com - January 4 at 8:19 AM
Allena Pharmaceuticals Price:Allena Pharmaceuticals Price:
ycharts.com - December 31 at 12:18 AM
Allena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 MillionAllena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 Million
finance.yahoo.com - December 2 at 12:52 AM
Allena Pharmaceuticals announces $10M bought dealAllena Pharmaceuticals announces $10M bought deal
seekingalpha.com - December 1 at 7:51 PM
Allena Pharmaceuticals Announces $10.0 Million Bought Deal OfferingAllena Pharmaceuticals Announces $10.0 Million Bought Deal Offering
finance.yahoo.com - December 1 at 7:51 PM
Allena Pharmaceuticals Announces Appointment of David J. Clark, M.D., M.R.C.P. as Chief Medical OfficerAllena Pharmaceuticals Announces Appointment of David J. Clark, M.D., M.R.C.P. as Chief Medical Officer
finance.yahoo.com - December 1 at 2:51 PM
Allena Pharmas ALLN-346 shows encouraging action in early-stage studyAllena Pharma's ALLN-346 shows encouraging action in early-stage study
seekingalpha.com - November 30 at 3:45 PM
DateCompanyBrokerageAction
11/10/2020PolarityTECantor FitzgeraldReiterated Rating
9/8/2020PolarityTEOppenheimerReiterated Rating
7/24/2020PolarityTENorthland SecuritiesReiterated Rating
5/12/2020PolarityTEHC WainwrightReiterated Rating
11/13/2019PolarityTEPiper Jaffray CompaniesLower Price Target
5/13/2019PolarityTENational SecuritiesLower Price Target
6/26/2020Windtree TherapeuticsLADENBURG THALM/SH SHInitiated Coverage
8/28/2020Brickell BiotechLake Street CapitalInitiated Coverage
10/1/2020Allena PharmaceuticalsB. RileyBoost Price Target
9/10/2020Allena PharmaceuticalsWedbushReiterated Rating
7/15/2020Allena PharmaceuticalsRoth CapitalReiterated Rating
2/17/2020Allena PharmaceuticalsCredit Suisse GroupReiterated Rating
11/14/2019Allena PharmaceuticalsCowenReiterated Rating
(Data available from 4/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.